175 related articles for article (PubMed ID: 1349150)
1. Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.
Ochoa MC; Vogelsang GD; Lum JT; VonVoigtlander PF; Piercey MF
Life Sci; 1992; 50(17):1225-33. PubMed ID: 1349150
[TBL] [Abstract][Full Text] [Related]
2. U-54494A: a unique anticonvulsant related to kappa opioid agonists.
VonVoigtlander PF; Hall ED; Ochoa MC; Lewis RA; Triezenberg HJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):542-7. PubMed ID: 2824750
[TBL] [Abstract][Full Text] [Related]
3. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.
Proietti ML; Scotti de Carolis A; Frank C; Zeng YC; Sagratella S
Neuropharmacology; 1991 Jun; 30(6):637-42. PubMed ID: 1656303
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of kainic acid lesions in the mouse hippocampus by U-54494A and U-50488H.
Camacho Ochoa M; Jackson TA; Aaron CS; Lahti RA; Strain GM; Von Voigtlander PF
Life Sci; 1992; 51(14):1135-43. PubMed ID: 1325589
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex.
De Sarro G; Trimarchi GR; Sinopoli S; Masuda Y; De Sarro A
Gen Pharmacol; 1993 Mar; 24(2):439-47. PubMed ID: 8387056
[TBL] [Abstract][Full Text] [Related]
6. The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat.
Hudson CJ; Von Voigtlander PF; Althaus JS; Scherch HM; Means ED
Brain Res; 1991 Nov; 564(2):261-7. PubMed ID: 1725768
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional interactions of a selective kappa opioid agonist with calcium.
VonVoigtlander PF; Ochoa MC; Lewis RA
Adv Exp Med Biol; 1987; 221():345-55. PubMed ID: 2829584
[TBL] [Abstract][Full Text] [Related]
8. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
Vonvoigtlander PF; Lewis RA
J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
[TBL] [Abstract][Full Text] [Related]
9. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant and related effects of U-54494A in various seizure tests.
Fischer W; Bodewei R; VonVoigtlander PF; Müller M
J Pharmacol Exp Ther; 1993 Oct; 267(1):163-70. PubMed ID: 8229743
[TBL] [Abstract][Full Text] [Related]
11. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
Alzheimer C; ten Bruggencate G
J Pharmacol Exp Ther; 1990 Nov; 255(2):900-5. PubMed ID: 1978733
[TBL] [Abstract][Full Text] [Related]
12. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
Li JG; Ma SC; Lu SN; Wang CQ
Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
[TBL] [Abstract][Full Text] [Related]
14. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
Piercey MF; Einspahr FJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
[TBL] [Abstract][Full Text] [Related]
15. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.
Pumford KM; Russell JA; Leng G
Exp Brain Res; 1993; 94(2):237-46. PubMed ID: 8395406
[TBL] [Abstract][Full Text] [Related]
16. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice.
Hiramatsu M; Hyodo T; Kameyama T
Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-synaptic effects of spiradoline and U-50488H, selective kappa opioid receptor agonists, in isolated ileum.
Nomura Y; Hayashi S
Scand J Gastroenterol; 1992 Apr; 27(4):295-302. PubMed ID: 1317055
[TBL] [Abstract][Full Text] [Related]
19. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
Pinnock RD
Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
